长春高新:公司子公司长春金赛药业有限责任公司收到美国FDA通知,授予GenSci128片孤儿药资格认定(ODD),用于胰腺癌的治疗。GenSci128片属治疗用化药1类新药,是针对TP53Y220C突变的选择性重激活剂,拟用于治疗携带TP53Y220C突变的局部晚期或转移性实体瘤,涵盖胰腺癌、卵巢癌、乳腺癌、结直肠癌等。TP53基因突变导致p53蛋白失活,是肿瘤发生的关键步骤,其中,...
Source Link长春高新:公司子公司长春金赛药业有限责任公司收到美国FDA通知,授予GenSci128片孤儿药资格认定(ODD),用于胰腺癌的治疗。GenSci128片属治疗用化药1类新药,是针对TP53Y220C突变的选择性重激活剂,拟用于治疗携带TP53Y220C突变的局部晚期或转移性实体瘤,涵盖胰腺癌、卵巢癌、乳腺癌、结直肠癌等。TP53基因突变导致p53蛋白失活,是肿瘤发生的关键步骤,其中,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.